Oklahoma HB1344 allows prescribers to issue off-label prescriptions with informed consent, exempts from disciplinary action, and prohibits WHO.
Oklahoma HB1344 establishes provisions for prescribing off-label medications. It allows prescribers to issue prescriptions for off-label drugs with informed consent from the patient, parent, guardian, or health care power of attorney. The bill exempts prescribers, pharmacists, and facilities from disciplinary action for expressing medical opinions on off-label drugs. It also prohibits any political subdivision, physician, or state agency from enforcing WHO guidelines within the state. The act takes effect November 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.